Arkolith/Insider Trading/PBLA/Form 4

Cullen Michael T.

Director, 10% OwnerPanbela Therapeutics, Inc. (PBLA) · full profile →Form 4 · filed Oct 6, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 4, 2022Buy(P)165K——370K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 4, 2022Buy(P)247K—$0247K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-22-023776) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML